Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

killer cells

Home/Tag:killer cells
28 02, 2013

RESEARCH NEWS: Path to safer, more effective SCTs discovered

Tags: , , , , , , |7 Comments

I tend to stay away from technical, preclinical science here at MMB.  Focusing on therapies that are doing well in human studies is one thing.  But lab studies in a test tube or mice?  A bit abstract for me--and I'm guessing many of you, too.  But I think this research is different.  Let me introduce

14 10, 2010

More About Using Killer Cells To Stop Multiple Myeloma

Tags: , |0 Comments

Yesterday I wrote an article about UAMS researcher's attempts to harness the power of "killer cells."  Here are links to several other articles about killer cell research I have written this past year:  Swiss Study Attempting To Kill Multiple Myeloma Using "Killer Cells!"http://www.helpwithcancer.org/2010/09/researchers-hope-our-bodys-rnai.htmlhttp://multiplemyelomablog.blogspot.com/2010/09/reader-question-what-is-mdx-1097.htmlDifferent approaches but same basic idea.  Hope something works! Feel good and keep smiling!  Pat

13 10, 2010

Killer Cell Research At UAMS Looks Promising!

Tags: , , , |0 Comments

This is potentially great news from DR. Frits van Rhee and other researchers at UAMS, focusing on ways to attack high risk multiple myeloma:“There are currently no good drugs available to tackle the high-risk disease,” said Frits van Rhee, M.D., Ph.D., who leads immunology research at the Myeloma Institute. “We can get patients into remission,

9 01, 2010

Swiss Study Attempting To Kill Multiple Myeloma Using "Killer Cells!"

Tags: , , , , , |0 Comments

Here is part of the summary I found on clinical trials.gov,  from an "out there" international study which is currently recruiting patients:High-dose chemotherapy with melphalan and autologous hematopoietic stem cell transplantation (HSCT) is considered standard treatment for patients with multiple myeloma. While autologous HSCT may induce remission in patients resistant to standard chemotherapy, and has